Today: 30 June 2026
Browse Category

NASDAQ:LFMD 17 November 2025

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss market This morning, LifeMD, Inc. unveiled what it calls the lowest cash‑pay pricing available nationwide for the GLP‑1 weight‑loss drugs Wegovy and Ozempic, in continued collaboration with Novo Nordisk. MarketScreener+3GlobeNewswire+3Quiver Quantitative+3
17 November 2025
··

Stock Market Today

  • Dycom Industries (DY) gains 12.6% in 12 weeks on momentum signals
    June 30, 2026, 10:23 AM EDT. Dycom Industries (DY) has put up a 12.6% price move over the past 12 weeks and is up 9.1% in the last month, showing steady price momentum for trend-focused investors. Shares are now trading at 96.2% of their 52-week range, which could point to a possible breakout. The stock carries a Zacks Rank #2 (Buy) and sits in the top 20% for earnings estimate revisions and earnings surprises-usually big for short-term swings. It also holds an Average Broker Recommendation of #1 (Strong Buy), often seen as a gauge of positive sentiment. This mix of price strength and solid analyst ratings is keeping DY on the radar of traders looking for momentum setups.
Go toTop